Wednesday, January 30, 2013

• AbbVie’s First Profit Forecast is Higher Than Estimatesat Bloomberg (Wed, Jan 30)
• C'est La Vie, AbbVie!at Motley Fool (Wed, Jan 30)
• Abbvie sets first annual guidance after spinoffAP (Wed, Jan 30)
• Abbvie sets first annual guidance after spin-offAP (Wed, Jan 30)
• U.S. Stock Options With Biggest Changes in Implied Volatilityat Bloomberg (Wed, Jan 30)
• What's in Regeneron's Pipes?at Motley Fool (Wed, Jan 30)
• Foolish Review: Pfizer Earningsat Motley Fool (Wed, Jan 30)
• AbbVie Issues Inaugural Full-Year Outlook for 2013PR Newswire (Wed, Jan 30)
• Zacks Industry Outlook Highlights: Johnson & Johnson, Hologic, Abbott Laboratories, AbbVie and Quest DiagnosticsZacks (Wed, Jan 30)
• Foolish Preview: Pfizer Earningsat Motley Fool (Wed, Jan 30)

Tuesday, January 29, 2013

• AbbVie Larger Than S&P 500 Component UnitedHealth Groupat Forbes (Tue, Jan 29)
• Foolish Preview: Vertex Earningsat Motley Fool (Tue, Jan 29)
• Cramer's Lightning Round - First Niagara Bit Off More Than It Could Chew (1/28/13)at Seeking Alpha (Tue, Jan 29)

Monday, January 28, 2013

• Shorts Are Piling Into These Stocks. Should You Be Worried?at Motley Fool (Mon, Jan 28)
• 4 Healthcare Stock Stories for Monday Wellnessat Wall St. Cheat Sheet (Mon, Jan 28)
• Gilead Could Be A Smart Play On Hepatitis C Market Growthat Seeking Alpha (Mon, Jan 28)
• Will Pfizer Earnings Move the Dow?at Motley Fool (Mon, Jan 28)
• The Best Selling Drugs of All Time; Humira Joins The Eliteat Forbes (Mon, Jan 28)
• At a 52-Week High, Is This Big Pharma Still a Buy?at Motley Fool (Mon, Jan 28)
• Is AbbVie's Overdependence on Humira a Long-Term Problem?at Forbes (Mon, Jan 28)
• ‘Harbaugh Bowl,’ Subway, Verizon: Intellectual Propertyat Bloomberg (Mon, Jan 28)
• One Pfizer or Two Pfizers?at Motley Fool (Mon, Jan 28)

Sunday, January 27, 2013

• A Detailed Look At Abbvieat Seeking Alpha (Sun, Jan 27)

Saturday, January 26, 2013

• Can Biologics Make You Rich?at Motley Fool (Sat, Jan 26)

Friday, January 25, 2013

• Abbott Labs -- Not AbbVie -- Is Acting Like a Spinoffat Motley Fool (Fri, Jan 25)

Add ABBV News to My Yahoo!